Showing results (151-160 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|March 1, 2019
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosisMarcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.Therapeutic Advances in Neurological Disorders|May 3, 2014
Sphenopalatine ganglion stimulation for the treatment of cluster headacheMiguel J A Láinez, Miguel Puche, Ana Garcia, et al.Therapeutic Advances in Neurological Disorders|August 27, 2019
The prevalence of intracranial stenosis in patients at low and moderate risk of strokeHong-Xiu Chen, Li-Juan Wang, Yi Yang, et al.Therapeutic Advances in Neurological Disorders|August 22, 2019
Therapeutic effect on experimental acute cerebral infarction is enhanced after nanoceria labeling of human umbilical cord mesenchymal stem cellsLian Zuo, Qishuai Feng, Yingying Han, et al.Therapeutic Advances in Neurological Disorders|August 27, 2019
Peripheral nerve disease secondary to systemic conditions in childrenJo M Wilmshurst, Robert A Ouvrier, Monique M RyanTherapeutic Advances in Neurological Disorders|July 20, 2019
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosisDaniel Merlo, David Darby, Tomas Kalincik, et al.Therapeutic Advances in Neurological Disorders|November 3, 2018
NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosisMarco Puthenparampil, Chiara Cazzola, Sofia Zywicki, et al.Therapeutic Advances in Neurological Disorders|July 31, 2019
Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravisJosep Gamez, María Salvadó, Francesc Carmona, et al.Therapeutic Advances in Neurological Disorders|September 7, 2019
Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two casesJeremias Motte, Janina Kneiphof, Katrin Straßburger-Krogias, et al.Therapeutic Advances in Neurological Disorders|November 2, 2016
Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence baseChristian Brandt, Theodor W May, Christian G BienPageof 108